Protagenic Therapeutics, Inc.new (PTIX) Gains (Losses) on Sale of Assets & Investments (2017 - 2024)
Protagenic Therapeutics, Inc.new (PTIX) reported Gains (Losses) on Sale of Assets & Investments of $7.31 million for FY2026 (year ended Mar 31, 2026).
Protagenic Therapeutics, Inc.new (PTIX) Gains (Losses) on Sale of Assets & Investments (2017 - 2024) Analysis & Trends
Dating back to FY2017, Protagenic Therapeutics, Inc.new's Gains (Losses) on Sale of Assets & Investments record includes 8 fiscal years.
- The FY2026 figure ranks as the highest annual Gains (Losses) on Sale of Assets & Investments in data going back to FY2017.
- According to Business Quant data, Gains (Losses) on Sale of Assets & Investments came in at $26,587 in FY2024 (+57.8%), $16,848 in FY2023 and -$421,738 in FY2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 51,534.00 |
| Mar 31, 2024 | 26,587.00 |
| Dec 31, 2023 | -38,655.00 |
| Sep 30, 2023 | -34,463.00 |
| Jun 30, 2023 | 42,289.00 |
| Mar 31, 2023 | 47,677.00 |
| Dec 31, 2022 | -61,238.00 |
| Sep 30, 2022 | -165,913.00 |
| Jun 30, 2022 | -43,417.00 |
| Mar 31, 2022 | -151,170.00 |
| Dec 31, 2021 | -76,055.00 |
| Sep 30, 2021 | -974.00 |
| Jun 30, 2021 | 482.00 |
| Mar 31, 2019 | 4,435.00 |
| Dec 31, 2018 | 1,003.00 |
| Sep 30, 2018 | 1,781.00 |
| Jun 30, 2018 | 3,541.00 |
| Mar 31, 2018 | -75.00 |
| Dec 31, 2017 | 572.00 |
| Sep 30, 2017 | 1,165.00 |
Protagenic Therapeutics, Inc.new Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();